Generic placeholder image

Current Molecular Medicine


ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

γ δ T Cells and Dendritic Cells: Close Partners and Biological Adjuvants for New Therapies

Author(s): Angelo Martino and Fabrizio Poccia

Volume 7, Issue 7, 2007

Page: [658 - 673] Pages: 16

DOI: 10.2174/156652407782564345

Price: $65


The knowledge of several signals influencing Dendritic Cell (DC) functions is crucial to manipulate the immune system for new vaccination therapies. Our recent findings provide a new model of intervention on DC system suggesting novel therapeutic implications. T, NK, and γ δ T cell stimuli may enhance DC maturation, Th polarization and trigger the adaptive immune response. Regulatory effects of γ δ T cells on inflammation and immune responses may be mediated by their interaction with DCs and they are analyzed in the last years in humans and mice. In humans, Vγ9Vδ2 T cells represent the most part of circulating γ δ T cells and are activated by non-peptidic molecules derived from different microorganisms or abnormal metabolic routes. They share both NK-like and effector/memory T cell features, and among these the possibility to interact with DCs. Coculture of immature DCs with activated Vγ9Vδ2 T cells allows DCs to acquire features of mature DCs complementing the migratory activity, up-regulating the chemokine receptors, and antigen presentation. Similarly to the NK-derived signals, DC activation is mostly mediated by soluble factors secreted by γ δ T cells. Many non-peptidic molecules including nitrogen-containing bisphosphonates and pyrophosphomonoester drugs stimulate the activity of Vγ9Vδ2 T cells in vitro and in vivo. The relatively low in vivo toxicity of many of these drugs makes possible novel vaccine and immune-based strategies, through DCs, for infectious and neoplastic diseases.

Keywords: γ δ T cells, dendritic cells, innate immunity, immunotherapy

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy